Marksans Pharma falls after its arm recalls Kroger Brand Aspirin and Ibuprofen bottles
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Marksans Pharma is currently trading at Rs. 41.60, down by 0.30 points or 0.72% from its previous closing of Rs. 41.90 on the BSE.
The scrip opened at Rs. 41.30 and has touched a high and low of Rs. 42.20 and Rs. 41.30 respectively. So far 24692 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 93.75 on 22-Jun-2021 and a 52 week low of Rs. 38.70 on 20-Jun-2022.
Last one week high and low of the scrip stood at Rs. 45.90 and Rs. 38.70 respectively. The current market cap of the company is Rs. 1706.84 crore.
The promoters holding in the company stood at 48.25%, while Institutions and Non-Institutions held 4.08% and 47.67% respectively.
Marksans Pharma’s wholly owned subsidiary--Time-Cap Laboratories Inc. has recalled Kroger Brand Aspirin (300 count bottles) and Ibuprofen (160 count bottles) due to label packaging issue to meet child resistant packaging requirement. Total 12 lots containing 209,430 units have been recalled.
Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.
